Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-18
2007-12-18
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
11083401
ABSTRACT:
Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one.
REFERENCES:
patent: 6420359 (2002-07-01), Simoneau
patent: 6759533 (2004-07-01), Busacca et al.
patent: 0196338 (2001-12-01), None
patent: 2004002989 (2004-01-01), None
Brittain, et al; “Polymorphism in Pharmaceutical Solids Passage”; Drug and Pharmaceutical Sciences, 1999, vol. 95, pp. 235-238.
Caira, M. R.; “Crystalline Polymorphism of Organic Compounds”; Topics in Current Chemistry; Springer, Berlin, Germany, 1999, vol. 198, pp. 163-208.
Busacca Carl A.
Cerreta Michael
Lorenz Jon
Smoliga John
Varsolona Richard
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Kifle Bruck
Morris Michael P.
Stempel Alan R.
LandOfFree
Crystalline forms of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3848698